How much revenue did MedPeer generate this year?
MedPeer has achieved a revenue of 15.48 B JPY this year.
MedPeer Revenue 2024
MedPeer Revenue
15.48 B JPY
Ticker
6095.T
ISIN
JP3921240002
WKN
A1153F
In 2024, MedPeer's sales reached 15.48 B JPY, a 6.44% difference from the 14.54 B JPY sales recorded in the previous year.
The MedPeer Revenue history
| YEAR | REVENUE (undefined JPY) | GROSS MARGIN (%) |
|---|---|---|
| 2027e | 21.58 | 31,81 |
| 2026e | 14.68 | 46,76 |
| 2025e | 14.74 | 46,60 |
| 2024e | 15.48 | 44,37 |
| 2023 | 14.54 | 47,22 |
| 2022 | 8.45 | 59,56 |
| 2021 | 7.44 | 65,29 |
| 2020 | 5.31 | 66,02 |
| 2019 | 3.05 | 69,52 |
| 2018 | 2.2 | 74,19 |
| 2017 | 1.56 | 75,47 |
| 2016 | 0.97 | 77,27 |
| 2015 | 1.04 | 85,61 |
| 2014 | 0.96 | 88,71 |
| 2013 | 0.57 | 86,11 |
| 2012 | 0.32 | 83,45 |
| 2011 | 0.14 | 73,95 |
| 2010 | 0.07 | 76,82 |
| 2009 | 0.05 | 93,03 |
MedPeer Revenue, EBIT, Net Income JP3921240002 · A1153F
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into MedPeer, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by MedPeer from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects MedPeer’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of MedPeer. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into MedPeer’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing MedPeer’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on MedPeer’s growth potential.
MedPeer Revenue, EBIT and net profit per share
| Date | MedPeer Revenue | MedPeer EBIT | MedPeer Net Income |
|---|---|---|---|
| 2027e | 21.58 B undefined | 0 undefined | 2.52 B undefined |
| 2026e | 14.68 B undefined | 0 undefined | 859.94 M undefined |
| 2025e | 14.74 B undefined | 0 undefined | 746.6 M undefined |
| 2024e | 15.48 B undefined | 0 undefined | 1.12 B undefined |
| 2023 | 14.54 B undefined | 1.12 B undefined | 617.68 M undefined |
| 2022 | 8.45 B undefined | 1.06 B undefined | 812.39 M undefined |
| 2021 | 7.44 B undefined | 1.78 B undefined | 1.29 B undefined |
| 2020 | 5.31 B undefined | 1.1 B undefined | 725.97 M undefined |
| 2019 | 3.05 B undefined | 558.43 M undefined | 394.85 M undefined |
| 2018 | 2.2 B undefined | 367.86 M undefined | 206.33 M undefined |
| 2017 | 1.56 B undefined | 82.34 M undefined | -363.27 M undefined |
| 2016 | 973.65 M undefined | 57.74 M undefined | 23.61 M undefined |
| 2015 | 1.04 B undefined | 136.47 M undefined | 70.4 M undefined |
| 2014 | 958.3 M undefined | 264.8 M undefined | 150.6 M undefined |
| 2013 | 574.7 M undefined | 89.2 M undefined | 113.6 M undefined |
| 2012 | 324.5 M undefined | 22.8 M undefined | 22.2 M undefined |
| 2011 | 138.6 M undefined | -83.8 M undefined | -85.5 M undefined |
| 2010 | 74.2 M undefined | -74.4 M undefined | -75.2 M undefined |
| 2009 | 54.5 M undefined | -23 M undefined | -23.8 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2009 | 54.5 M JPY | -23 M JPY | -23.8 M JPY |
| 2010 | 74.2 M JPY | -74.4 M JPY | -75.2 M JPY |
| 2011 | 138.6 M JPY | -83.8 M JPY | -85.5 M JPY |
| 2012 | 324.5 M JPY | 22.8 M JPY | 22.2 M JPY |
| 2013 | 574.7 M JPY | 89.2 M JPY | 113.6 M JPY |
| 2014 | 958.3 M JPY | 264.8 M JPY | 150.6 M JPY |
| 2015 | 1.04 B JPY | 136.47 M JPY | 70.4 M JPY |
| 2016 | 973.65 M JPY | 57.74 M JPY | 23.61 M JPY |
| 2017 | 1.56 B JPY | 82.34 M JPY | -363.27 M JPY |
| 2018 | 2.2 B JPY | 367.86 M JPY | 206.33 M JPY |
| 2019 | 3.05 B JPY | 558.43 M JPY | 394.85 M JPY |
| 2020 | 5.31 B JPY | 1.1 B JPY | 725.97 M JPY |
| 2021 | 7.44 B JPY | 1.78 B JPY | 1.29 B JPY |
| 2022 | 8.45 B JPY | 1.06 B JPY | 812.39 M JPY |
| 2023 | 14.54 B JPY | 1.12 B JPY | 617.68 M JPY |
| 2024e | 15.48 B JPY | 0 JPY | 1.12 B JPY |
| 2025e | 14.74 B JPY | 0 JPY | 746.6 M JPY |
| 2026e | 14.68 B JPY | 0 JPY | 859.94 M JPY |
| 2027e | 21.58 B JPY | 0 JPY | 2.52 B JPY |
MedPeer stock margins JP3921240002 · A1153F
The MedPeer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MedPeer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MedPeer.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the MedPeer's sales revenue. A higher gross margin percentage indicates that the MedPeer retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the MedPeer's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the MedPeer's total revenue generated. When comparing the revenue margin year over year, investors can gauge the MedPeer's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the MedPeer. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the MedPeer's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
MedPeer Margin History
| MedPeer Gross margin | MedPeer Profit margin | MedPeer EBIT margin | MedPeer Profit margin |
|---|---|---|---|
| 2027e | 47.22 % | 0 % | 11.68 % |
| 2026e | 47.22 % | 0 % | 5.86 % |
| 2025e | 47.22 % | 0 % | 5.07 % |
| 2024e | 47.22 % | 0 % | 7.21 % |
| 2023 | 47.22 % | 7.7 % | 4.25 % |
| 2022 | 59.56 % | 12.59 % | 9.61 % |
| 2021 | 65.29 % | 23.99 % | 17.4 % |
| 2020 | 66.02 % | 20.8 % | 13.67 % |
| 2019 | 69.52 % | 18.34 % | 12.96 % |
| 2018 | 74.19 % | 16.73 % | 9.38 % |
| 2017 | 75.47 % | 5.28 % | -23.3 % |
| 2016 | 77.27 % | 5.93 % | 2.43 % |
| 2015 | 85.61 % | 13.12 % | 6.77 % |
| 2014 | 88.71 % | 27.63 % | 15.72 % |
| 2013 | 86.11 % | 15.52 % | 19.77 % |
| 2012 | 83.45 % | 7.03 % | 6.84 % |
| 2011 | 73.95 % | -60.46 % | -61.69 % |
| 2010 | 76.82 % | -100.27 % | -101.35 % |
| 2009 | 93.03 % | -42.2 % | -43.67 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2009 | 93.03 % | -42.2 % | -43.67 % |
| 2010 | 76.82 % | -100.27 % | -101.35 % |
| 2011 | 73.95 % | -60.46 % | -61.69 % |
| 2012 | 83.45 % | 7.03 % | 6.84 % |
| 2013 | 86.11 % | 15.52 % | 19.77 % |
| 2014 | 88.71 % | 27.63 % | 15.72 % |
| 2015 | 85.61 % | 13.12 % | 6.77 % |
| 2016 | 77.27 % | 5.93 % | 2.43 % |
| 2017 | 75.47 % | 5.28 % | -23.3 % |
| 2018 | 74.19 % | 16.73 % | 9.38 % |
| 2019 | 69.52 % | 18.34 % | 12.96 % |
| 2020 | 66.02 % | 20.8 % | 13.67 % |
| 2021 | 65.29 % | 23.99 % | 17.4 % |
| 2022 | 59.56 % | 12.59 % | 9.61 % |
| 2023 | 47.22 % | 7.7 % | 4.25 % |
| 2024e | 47.22 % | 0 % | 7.21 % |
| 2025e | 47.22 % | 0 % | 5.07 % |
| 2026e | 47.22 % | 0 % | 5.86 % |
| 2027e | 47.22 % | 0 % | 11.68 % |
MedPeer Aktienanalyse
What does MedPeer do?
MedPeer Inc is a US-American company that was founded in Boston, Massachusetts in 2004. The company develops and operates social networks and platforms for doctors and medical students. The business model of MedPeer is focused on bringing doctors and medical students together on a platform where they can exchange medical information, ask and answer questions, and engage in discussions on current medical topics. MedPeer is primarily a platform that provides information and support to medical professionals and facilitates the exchange of valuable information. MedPeer also offers various specialized sections that provide specific information and support to doctors and medical students. These sections include, among others, gastroenterology, cardiology, oncology, neurology, dermatology, and mental health. In the field of gastroenterology, MedPeer provides information on the diagnosis and treatment of gastrointestinal diseases. In the field of cardiology, MedPeer provides information on the diagnosis and treatment of cardiovascular diseases. In the field of oncology, MedPeer provides information on cancer treatment. In the field of neurology, MedPeer provides information on the treatment of neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. In the field of dermatology, MedPeer provides information on the diagnosis and treatment of skin diseases. In the field of mental health, MedPeer provides information on the diagnosis and treatment of mental illnesses such as depression and anxiety. MedPeer also offers products that are designed to assist doctors and medical students in their work and studies. An example of this is the MedPeer Academy course, which prepares medical students for their clinical rotations and prepares them for the exam they must take at the end of their rotation period. Other products offered by MedPeer include digital medical libraries that provide access to thousands of medical articles, journals, and textbooks. Additionally, MedPeer offers various software tools designed to assist doctors in the diagnosis and treatment of patients. Over the years, MedPeer has received several awards and recognitions, including first place in the "Medical Services and Equipment" category at the Global Mobile Awards 2014. Furthermore, the company has received a significant amount of venture capital investments in recent years. The company has also recently entered into a partnership with Allm, a Japanese provider of mobile and web applications for the healthcare sector. The partnership aims to allow MedPeer to enter the Japanese market and expand its services and products to a larger audience. Overall, MedPeer has made significant progress in recent years and has become a key player in the medical information and communication industry. The company has demonstrated its ability to provide high-quality products and services that can assist doctors and medical students in their work and studies. MedPeer ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding MedPeer's Sales Figures
The sales figures of MedPeer originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing MedPeer’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize MedPeer's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in MedPeer’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about MedPeer stock
How much was the turnover of the company MedPeer compared to the previous year?
The revenue of MedPeer has increased by 6.44% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of MedPeer?
The revenue of MedPeer is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of MedPeer measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of MedPeer so important for investors?
The revenue of MedPeer is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does MedPeer pay?
Over the past 12 months, MedPeer paid a dividend of 4.5 JPY . This corresponds to a dividend yield of about 0.8 %. For the coming 12 months, MedPeer is expected to pay a dividend of 4.5 JPY.
What is the dividend yield of MedPeer?
The current dividend yield of MedPeer is 0.8 %.
When does MedPeer pay dividends?
MedPeer pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MedPeer?
MedPeer paid dividends every year for the past 0 years.
What is the dividend of MedPeer?
For the upcoming 12 months, dividends amounting to 4.5 JPY are expected. This corresponds to a dividend yield of 0.8 %.
In which sector is MedPeer located?
MedPeer is assigned to the 'Health' sector.
Wann musste ich die Aktien von MedPeer kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MedPeer from 12/1/2024 amounting to 4.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did MedPeer pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of MedPeer in the year 2023?
In the year 2023, MedPeer distributed 0 JPY as dividends.
In which currency does MedPeer pay out the dividend?
The dividends of MedPeer are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von MedPeer
Our stock analysis for MedPeer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedPeer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.